Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AEMD)

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Newsfile 8 days ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

PR Newswire 9 days ago

Innovative Medical Technology Advances with First Patient Enrollments

Newsfile 10 days ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

PR Newswire 11 days ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

PR Newswire November 6, 2024

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

PR Newswire October 8, 2024

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Newsfile September 19, 2024

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

PR Newswire September 19, 2024

Aethlon Medical to Present at Virtual Investor Conferences in September

PR Newswire September 17, 2024
View More News ››

Opinion & Analysis (NDAQ:AEMD)

Exosome Sciences uncovers biomarker candidate to ID Players with CTE

The Life Sciences Report May 6, 2016

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary

Gail Dutton December 23, 2015

Aethlon Medical's biofiltration platform tackles everything from ebola to cancer: CEO James Joyce

Gail Dutton October 30, 2015

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of SeeThruEquity

Gail Dutton October 30, 2015

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015

Four small-cap medtech primed for outsize returns: Zacks' Brian Marckx

The Life Sciences Report July 15, 2015
View More Opinion ››

Bullboard Posts (NDAQ:AEMD)

Aethlon Medical Reaches Key Milestone with Enrollment of the

Breaking News: $AEMD Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier&#xAE...
whytestocks - 11 days ago

Immunotherapy Clinical Trials - A New Approach to Treating C

News; $AEMD Immunotherapy Clinical Trials - A New Approach to Treating CancerVancouver, Kelowna, and Delta, British Columbia--(Newsfile...
whytestocks - September 19, 2024

The Cancer Battle - How Smaller Companies Are Making Big Adv

JUST IN: $AEMD The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid TumorsVancouver, Kelowna...
whytestocks - August 12, 2024

AEMD....lots of warrants still O/S......Caveat Emptor IMHO !

AETHLON MEDICAL, INC. 8-K (sec.gov)
Iseneschal - June 6, 2024

Excellent new YouTube analysis on AEMD

https://youtu.be/x1ZloEX6UX4?si=trNXxFtD7mFMknm6
BryceCanada - June 2, 2024

What's Going On With Medical Therapeutic Firm Aethlon Medica

JUST IN: $AEMD What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? | BenzingaFriday,@Aethlon Medical Inc...
whytestocks - May 10, 2024
View more Bullboard ››

Biosenta Inc.

Biosenta Inc.

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ...
View More »